About: Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1986

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1986 (uk) im Januar 1986 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1986 (ast) artikull shkencor i botuar më 01 janar 1986 (sq) scientific article published on 01 January 1986 (en)
publication date	wds:Q69752093-07ED028B-2DCF-4676-960F-9EA1A81C086A
publication date	1986-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q69752093-C4BADEEA-834A-4A0C-A85C-850F017FD9C6
exact match	https://scigraph.springernature.com/pub.10.1007/bf00179595
cites work	wds:Q69752093-04125FCC-FB5D-427B-BDDA-F1BAB304B9B3 wds:Q69752093-33D314F9-3B8A-4B7F-AD81-1A1C293F3A83 wds:Q69752093-5DDBCE6F-1CC1-4A4F-9027-13C53A0E709E wds:Q69752093-6F0E4907-79D5-428A-8494-CD7447F972E7 wds:Q69752093-96A7A58F-FE4C-40E6-BA7F-AFD69B097DEB wds:Q69752093-97618BF0-3D59-43DE-823B-7437FB454C32
cites work	Adriamycin. A new anticancer drug with significant clinical activity Antitumor activity of esorubicin in human tumor clonogenic assay with comparisons to doxorubicin. Phase I trial of esorubicin (4'deoxydoxorubicin). Experimental evaluation of anthracycline analogs The human tumor clonogenic assay in human breast cancer. Phase II trial of 4'-deoxydoxorubicin in patients with advanced breast cancer.
author name string	wds:Q69752093-2E467C45-0739-45E3-9CB3-B0972BA9C0DF wds:Q69752093-2F923567-985C-4D88-B7A9-9060848668DD wds:Q69752093-41DB12B0-EDB0-492C-85A9-8194443F780C wds:Q69752093-AD2F8FB9-2D42-4E72-AC88-48E60FB771D2 wds:Q69752093-BE45EF18-E0CC-4090-BCFC-868CAFD99C34
author name string	H S Garewal S E Jones T P Miller A Robertone T A Braich
rdfs:label	Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (en) Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (nl) Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (sq)
skos:prefLabel	Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (en) Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (nl) Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (sq)
name	Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (en) Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (nl) Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (sq)
author	wds:Q69752093-0070B56A-9F18-4F07-9FFD-89EFF791CC22 wds:Q69752093-44EC1FF5-C4A0-4688-B07D-FA8C44F9EE5F
author	David S. Alberts Sydney E. Salmon
title	wds:Q69752093-355593C6-8AC3-41F9-98E3-6294719CF63A
title	Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma (en)
page(s)	wds:Q69752093-D1EBFCF4-3629-4919-82E9-539A23987773
page(s)	269-274
instance of	wds:Q69752093-E2EAFB5B-E684-42CB-9140-C540946C5B32
instance of	scholarly article
main subject	wds:Q69752093-237749BD-B5FB-41BD-9768-5C2FB6BEAE7A
main subject	phase II clinical trial
PubMed ID	wds:Q69752093-71367C5C-AF17-4491-A7F0-EDFB46BBD387
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3818231
PubMed ID	3818231
published in	wds:Q69752093-183DE713-C66A-4786-8F18-A16CBB3199D7
published in	Investigational New Drugs
issue	wds:Q69752093-903B1D48-774B-43D7-923A-D38AC2F071B5
volume	wds:Q69752093-66A21733-3A93-45CF-8009-90E49AD72BF9
issue	3
volume	4
DOI	wds:Q69752093-87F333FB-6D27-41B7-AC08-BC9C1731FF82
DOI	http://dx.doi.org/10.1007/BF00179595
DOI	10.1007/BF00179595
Dimensions Publication ID	wds:Q69752093-A154AFDB-A142-461C-AB01-D637F73F4E5F
Dimensions Publication ID	1050062923
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69752093
is cites work of	Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685). Clinical cardiotoxicity of esorubicin (4'-deoxydoxorubicin,DxDx): prospective studies with serial gated heart scans and reports of selected cases. A Cancer and Leukemia Group B report Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer
is cites work of	wds:Q33401941-5A6C4AEC-47CF-466A-BADD-0D749A536584 wds:Q28330610-AA2C138D-AD01-40E0-8A58-19D44B742EEF wds:Q70296789-F42FDCE2-19D0-4C8C-9B6D-1B4C86967FA0

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software